Beauty products company Coty (NYSE:COTY) announced better-than-expected revenue in Q4 CY2025, but sales were flat year on year at $1.68 billion. Its non-GAAP profit of $0.14 per share was 24.2% below analysts’ consensus estimates.

Is now the time to buy Coty? Find out in our full research report.

Revenue: $1.68 billion vs analyst estimates of $1.66 billion (flat year on year, 1.1% beat)

Adjusted EPS: $0.14 vs analyst expectations of $0.18 (24.2% miss)

Adjusted EBITDA: $330.2 million vs analyst estimates of $338.1 million (19.7% margin, 2.3% miss)

Operating Margin: 8.8%, down from 16.1% in the same quarter last year

Free Cash Flow Margin: 30.6%, up from 25.1% in the same quarter last year

Organic Revenue fell 3% year on year (beat)

Market Capitalization: $3 billion

With a portfolio boasting many household brands, Coty (NYSE:COTY) is a beauty products powerhouse spanning cosmetics, fragrances, and skincare.

A company’s long-term sales performance is one signal of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years.

With $5.81 billion in revenue over the past 12 months, Coty carries some recognizable products but is a mid-sized consumer staples company. Its size could bring disadvantages compared to larger competitors benefiting from better brand awareness and economies of scale.

As you can see below, Coty’s sales grew at a sluggish 3.3% compounded annual growth rate over the last three years. This shows it failed to generate demand in any major way and is a rough starting point for our analysis.

This quarter, Coty’s $1.68 billion of revenue was flat year on year but beat Wall Street’s estimates by 1.1%.

Looking ahead, sell-side analysts expect revenue to grow 3% over the next 12 months, similar to its three-year rate. This projection doesn't excite us and implies its newer products will not accelerate its top-line performance yet.

While Wall Street chases Nvidia at all-time highs, an under-the-radar semiconductor supplier is dominating a critical AI component these giants can’t build without. Click here to access our free report one of our favorites growth stories.

When analyzing revenue growth, we care most about organic revenue growth. This metric captures a business’s performance excluding one-time events such as mergers, acquisitions, and divestitures as well as foreign currency fluctuations.

Coty’s demand has been falling over the last eight quarters, and on average, its organic sales have declined by 4.8% year on year.

In the latest quarter, Coty’s organic sales fell by 3% year on year. This decrease represents a further deceleration from its historical levels. We hope the business can get back on track.

It was good to see Coty narrowly top analysts’ revenue expectations this quarter. We were also happy its organic revenue was in line with Wall Street’s estimates. On the other hand, its EPS missed and its EBITDA fell short of Wall Street’s estimates. Overall, this quarter could have been better. The stock traded down 14% to $2.71 immediately after reporting.

Coty’s earnings report left more to be desired. Let’s look forward to see if this quarter has created an opportunity to buy the stock. We think that the latest quarter is just one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here, it’s free.